←Back to structures
EGF-like_domain
Euk-VirMollivirus_sibericum_Viruses.
EGF-like_domain__YP_009165132__Mollivirus_sibericum_Viruses.__X
Identity
- Accession:
- YP_009165132 ↗
- Protein ID:
- EGF-like_domain
- Kingdom:
- euk
Quality
70.4
mean pLDDT
Cluster
View cluster (17 members)3D Structure
Domains
high = three domain segmentations agree, medium = two domain segmentations agree. Numbered high-first then medium, N→C within each tier.
D1
high
residues 65-108_131-204
Domain cluster:
representative
CATH (56)
| Domain ID | Class ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 4r80A00 | 3.10.450.630 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.77 | 48.0 | 5.78e-01 | 100.0% | 96.1% |
| 2cc3A00 | 3.10.450.230 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › VirB8 protein | 0.74 | 69.0 | 6.42e-01 | 100.0% | 93.8% |
| 3f9sB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.72 | 68.0 | 6.33e-01 | 100.0% | 92.2% |
| 3kkgA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.72 | 68.0 | 6.29e-01 | 100.0% | 88.9% |
| 1idpA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.72 | 67.0 | 6.17e-01 | 100.0% | 95.2% |
| 4kz1A00 | 3.10.450.230 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › VirB8 protein | 0.72 | 66.0 | 6.33e-01 | 98.3% | 100.0% |
| 3soyA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.72 | 67.0 | 6.23e-01 | 100.0% | 91.5% |
| 4jf8A00 | 3.10.450.230 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › VirB8 protein | 0.72 | 66.0 | 6.17e-01 | 99.2% | 93.8% |
| 4gb5A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.71 | 66.0 | 6.11e-01 | 100.0% | 91.2% |
| 3a76A01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.71 | 67.0 | 6.29e-01 | 100.0% | 91.4% |
| 3d9rB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.71 | 67.0 | 6.39e-01 | 100.0% | 94.7% |
| 4o3vA00 | 3.10.450.230 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › VirB8 protein | 0.71 | 66.0 | 6.27e-01 | 100.0% | 95.7% |
| 5i97C00 | 3.10.450.230 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › VirB8 protein | 0.71 | 65.0 | 6.16e-01 | 98.3% | 100.0% |
| 2gexA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.70 | 66.0 | 6.08e-01 | 100.0% | 84.9% |
| 4lgqA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.70 | 65.0 | 6.25e-01 | 99.2% | 94.7% |
| 3b8lA01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.70 | 65.0 | 6.09e-01 | 100.0% | 92.2% |
| 4l8oA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.69 | 64.0 | 5.71e-01 | 100.0% | 77.4% |
| 3ff0A01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.69 | 65.0 | 6.07e-01 | 100.0% | 90.1% |
| 3ef8A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.69 | 64.0 | 5.90e-01 | 100.0% | 85.8% |
| 3cnxA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.69 | 64.0 | 6.05e-01 | 100.0% | 96.4% |
| 3ehcB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.68 | 63.0 | 6.18e-01 | 100.0% | 93.8% |
| 1jkgB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.67 | 62.0 | 5.34e-01 | 100.0% | 83.9% |
| 2gtlN02 | 2.40.128.620 | Mainly Beta › Beta Barrel › Lipocalin › | 0.67 | 50.0 | 4.41e-01 | 100.0% | 54.1% |
| 3e99A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.67 | 61.0 | 5.66e-01 | 100.0% | 93.2% |
| 2rfrA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.67 | 62.0 | 5.62e-01 | 100.0% | 82.5% |
| 2chcC00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.66 | 61.0 | 5.50e-01 | 100.0% | 82.4% |
| 1eq6A00 | 3.40.1000.10 | Alpha Beta › 3-Layer(aba) Sandwich › Protein Transport Mog1p; Chain A › Mog1/PsbP, alpha/beta/alpha sandwich | 0.66 | 45.0 | 3.83e-01 | 100.0% | 43.4% |
| 2f86B00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.66 | 59.0 | 5.79e-01 | 97.5% | 95.3% |
| 3gwrB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.66 | 60.0 | 5.86e-01 | 98.3% | 96.1% |
| 6hpvA01 | 3.10.450.10 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.66 | 43.0 | 4.99e-01 | 96.6% | 92.9% |
| 3gzrB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.66 | 60.0 | 5.66e-01 | 100.0% | 91.5% |
| 3cu3A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.66 | 61.0 | 5.43e-01 | 100.0% | 79.6% |
| 3f7sA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.66 | 61.0 | 5.68e-01 | 100.0% | 93.0% |
| 1vqqA01 | 3.10.450.100 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › NTF2-like; domain 1 | 0.65 | 56.0 | 5.84e-01 | 94.9% | 100.0% |
| 2ckfB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.65 | 60.0 | 5.28e-01 | 100.0% | 90.6% |
| 3hx8A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.65 | 59.0 | 5.80e-01 | 100.0% | 96.9% |
| 1uliB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.65 | 60.0 | 5.19e-01 | 100.0% | 89.3% |
| 2rgqB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.65 | 60.0 | 5.80e-01 | 100.0% | 92.5% |
| 2bmoB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.65 | 59.0 | 4.98e-01 | 100.0% | 80.4% |
| 1ar0A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.65 | 60.0 | 5.90e-01 | 100.0% | 94.4% |
| 3h51A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.64 | 59.0 | 5.55e-01 | 100.0% | 88.7% |
| 3fsdA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.64 | 58.0 | 5.83e-01 | 99.2% | 100.0% |
| 3b7cA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.62 | 56.0 | 5.63e-01 | 97.5% | 100.0% |
| 3nv0B00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.62 | 57.0 | 5.43e-01 | 99.2% | 89.7% |
| 4i4kA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.62 | 56.0 | 5.36e-01 | 100.0% | 92.0% |
| 3ebyA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.61 | 55.0 | 5.10e-01 | 100.0% | 92.2% |
| 3q90B00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.61 | 56.0 | 5.46e-01 | 100.0% | 91.5% |
| 5bkaE01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.60 | 53.0 | 5.13e-01 | 99.2% | 100.0% |
| 1jkgA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.59 | 54.0 | 5.10e-01 | 100.0% | 93.5% |
| 2obdA02 | 3.15.10.10 | Alpha Beta › Super Roll › Bactericidal permeability-increasing protein; domain 1 › Bactericidal permeability-increasing protein; domain 1 | 0.56 | 52.0 | 4.41e-01 | 100.0% | 67.7% |
| 4q52A00 | 2.60.40.3910 | Mainly Beta › Sandwich › Immunoglobulin-like › Inclusion body protein | 0.53 | 41.0 | 3.63e-01 | 82.2% | 100.0% |
| 1w7cA03 | 3.10.450.40 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.53 | 41.0 | 4.21e-01 | 100.0% | 86.1% |
| 3wodG00 | 2.30.30.1250 | Mainly Beta › Roll › SH3 type barrels. › | 0.52 | 37.0 | 3.65e-01 | 100.0% | 67.7% |
| 4kghA00 | 3.15.10.10 | Alpha Beta › Super Roll › Bactericidal permeability-increasing protein; domain 1 › Bactericidal permeability-increasing protein; domain 1 | 0.52 | 46.0 | 3.98e-01 | 100.0% | 66.8% |
| 3gp6A00 | 2.40.160.20 | Mainly Beta › Beta Barrel › Porin › | 0.51 | 45.0 | 4.11e-01 | 96.6% | 76.1% |
| 3mswA00 | 2.40.128.720 | Mainly Beta › Beta Barrel › Lipocalin › | 0.50 | 32.0 | 3.07e-01 | 95.8% | 53.2% |
ECOD (74)
| UID | F-ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 3696424 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.73 | 68.0 | 6.26e-01 | 100.0% | 88.7% |
| 3950026 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.72 | 67.0 | 6.40e-01 | 99.2% | 92.5% |
| 3959230 | 243.1.1.77 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF29518 | 0.72 | 65.0 | 6.14e-01 | 96.6% | 87.1% |
| 3288890 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.72 | 64.0 | 6.21e-01 | 94.9% | 92.3% |
| 3961898 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.72 | 64.0 | 6.23e-01 | 94.9% | 92.3% |
| 4352488 | 243.1.1.6 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › VirB8 | 0.72 | 67.0 | 6.15e-01 | 100.0% | 94.0% |
| 3962922 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.72 | 66.0 | 5.89e-01 | 100.0% | 77.0% |
| 3951229 | 243.1.1.77 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF29518 | 0.71 | 64.0 | 5.95e-01 | 97.5% | 82.3% |
| 3818687 | 243.1.1.49 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF2358 | 0.71 | 66.0 | 6.11e-01 | 100.0% | 91.0% |
| 3958465 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.71 | 63.0 | 5.75e-01 | 94.9% | 80.0% |
| 4022303 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.71 | 66.0 | 6.03e-01 | 100.0% | 83.3% |
| 5072383 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.70 | 65.0 | 6.08e-01 | 100.0% | 87.6% |
| 1146680 | 243.1.1.6 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › VirB8 | 0.70 | 66.0 | 6.10e-01 | 100.0% | 95.1% |
| 3216011 | 243.1.1.109 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF5382, DUF5382_C | 0.70 | 64.0 | 4.71e-01 | 99.2% | 44.4% |
| 5010039 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.70 | 65.0 | 5.95e-01 | 100.0% | 87.3% |
| 6410 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.70 | 65.0 | 6.04e-01 | 100.0% | 90.3% |
| 3284019 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.70 | 65.0 | 6.17e-01 | 100.0% | 94.1% |
| 4106765 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.69 | 64.0 | 6.24e-01 | 100.0% | 93.8% |
| 5026021 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.69 | 64.0 | 6.03e-01 | 100.0% | 97.1% |
| 3479831 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.69 | 64.0 | 5.64e-01 | 100.0% | 79.4% |
| 3727006 | 243.1.1.9 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF1348 | 0.69 | 64.0 | 5.66e-01 | 100.0% | 73.8% |
| 3967916 | 243.1.1.25 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_3 | 0.69 | 64.0 | 5.90e-01 | 100.0% | 89.9% |
| 3282685 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.69 | 61.0 | 6.12e-01 | 95.8% | 100.0% |
| 4135737 | 243.1.1.66 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › TcaA_5th | 0.69 | 61.0 | 6.20e-01 | 95.8% | 99.1% |
| 3285746 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.69 | 64.0 | 5.80e-01 | 100.0% | 80.6% |
| 3848773 | 243.1.1.13 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › CaMKII_AD | 0.68 | 63.0 | 5.59e-01 | 99.2% | 77.6% |
| 3287787 | 243.1.1.25 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_3 | 0.68 | 63.0 | 5.92e-01 | 99.2% | 95.0% |
| 4283272 | 243.1.1.1 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Ring_hydroxyl_B | 0.68 | 63.0 | 5.53e-01 | 100.0% | 85.9% |
| 3504070 | 243.1.1.13 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › CaMKII_AD | 0.68 | 62.0 | 5.77e-01 | 99.2% | 89.7% |
| 5009713 | 243.1.1.1 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Ring_hydroxyl_B | 0.67 | 62.0 | 5.58e-01 | 100.0% | 93.8% |
| 4315252 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.67 | 61.0 | 5.74e-01 | 100.0% | 89.7% |
| 3893447 | 243.1.1.40 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NXF_NTF2 | 0.67 | 62.0 | 5.21e-01 | 100.0% | 80.5% |
| 4974050 | 243.1.1.25 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_3 | 0.67 | 62.0 | 5.93e-01 | 100.0% | 94.1% |
| 3287136 | 243.1.1.25 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_3 | 0.67 | 62.0 | 5.98e-01 | 99.2% | 97.7% |
| 6407 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.67 | 62.0 | 5.63e-01 | 100.0% | 83.0% |
| 3947325 | 243.1.1.56 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF2895 | 0.67 | 61.0 | 5.71e-01 | 100.0% | 98.6% |
| 3279484 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.67 | 60.0 | 5.80e-01 | 100.0% | 95.6% |
| 6402 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.66 | 61.0 | 5.42e-01 | 100.0% | 78.4% |
| 3277859 | 243.1.1.25 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_3 | 0.66 | 61.0 | 5.95e-01 | 99.2% | 96.9% |
| 4664562 | 243.1.1.1 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Ring_hydroxyl_B | 0.66 | 61.0 | 5.29e-01 | 100.0% | 88.6% |
| 3288819 | 243.1.1.25 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_3 | 0.66 | 60.0 | 5.58e-01 | 100.0% | 91.3% |
| 361002 | 243.1.1.25 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_3 | 0.66 | 60.0 | 5.84e-01 | 98.3% | 95.3% |
| 134562 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.66 | 60.0 | 5.64e-01 | 100.0% | 90.2% |
| 6409 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.66 | 61.0 | 5.43e-01 | 100.0% | 79.6% |
| 2632036 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.66 | 61.0 | 5.75e-01 | 100.0% | 94.2% |
| 3285905 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.66 | 58.0 | 5.61e-01 | 95.8% | 91.5% |
| 163051 | 243.1.1.1 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Ring_hydroxyl_B | 0.65 | 60.0 | 5.28e-01 | 100.0% | 90.6% |
| 3277986 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.65 | 60.0 | 5.88e-01 | 100.0% | 94.6% |
| 6401 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.65 | 61.0 | 5.83e-01 | 100.0% | 92.5% |
| 1684828 | 243.1.1.67 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Cds6_C | 0.65 | 58.0 | 5.65e-01 | 94.9% | 92.9% |
| 3962910 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.65 | 60.0 | 5.72e-01 | 100.0% | 97.0% |
| 139114 | 243.1.1.1 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Ring_hydroxyl_B | 0.65 | 59.0 | 5.07e-01 | 100.0% | 84.9% |
| 5047377 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.64 | 59.0 | 5.57e-01 | 99.2% | 97.9% |
| 134734 | 243.1.1.13 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › CaMKII_AD | 0.64 | 59.0 | 5.55e-01 | 100.0% | 88.7% |
| 2628859 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.64 | 59.0 | 5.68e-01 | 100.0% | 98.5% |
| 154434 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.62 | 56.0 | 5.36e-01 | 100.0% | 92.0% |
| 3961200 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.62 | 56.0 | 5.36e-01 | 100.0% | 88.9% |
| 3216464 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.61 | 56.0 | 5.51e-01 | 100.0% | 98.4% |
| 3286225 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.60 | 55.0 | 5.33e-01 | 100.0% | 98.5% |
| 1125573 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.60 | 55.0 | 5.33e-01 | 100.0% | 98.4% |
| 3722444 | 243.1.1.25 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_3 | 0.60 | 54.0 | 4.72e-01 | 100.0% | 75.0% |
| 3859609 | 243.1.1.40 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NXF_NTF2 | 0.59 | 53.0 | 4.56e-01 | 100.0% | 87.4% |
| 3725346 | 243.1.1.25 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_3 | 0.56 | 46.0 | 4.51e-01 | 88.1% | 83.1% |
| 3465790 | 243.3.1.19 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › DUF3615 | 0.54 | 49.0 | 4.03e-01 | 99.2% | 81.9% |
| 3173251 | 4051.1.1.1 ↗ | a+b two layers › a+b domain in Capz › a+b domain in Capz › a+b domain in Capz › F_actin_cap_B | 0.53 | 46.0 | 4.05e-01 | 100.0% | 65.3% |
| 3936550 | 883.1.1.2 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like › LBP_BPI_CETP_C | 0.53 | 48.0 | 3.16e-01 | 100.0% | 25.8% |
| 3718042 | 5.1.3.28 ↗ | beta duplicates or obligate multimers › beta-propeller-like › beta-propeller › 6-bladed › BNR_3 | 0.53 | 47.0 | 3.22e-01 | 100.0% | 34.7% |
| 3749143 | 243.3.1.20 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › AKAP28 | 0.52 | 44.0 | 4.38e-01 | 99.2% | 88.0% |
| 3584293 | 883.1.1.0 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like | 0.52 | 47.0 | 3.67e-01 | 100.0% | 56.5% |
| 3594616 | 1100.1.1.0 ↗ | beta meanders › TIP41-like protein › TIP41-like protein › TIP41-like protein | 0.52 | 40.0 | 3.23e-01 | 100.0% | 40.4% |
| 3441483 | 5.1.3.68 ↗ | beta duplicates or obligate multimers › beta-propeller-like › beta-propeller › 6-bladed › DUF1618 | 0.52 | 46.0 | 3.30e-01 | 100.0% | 35.9% |
| 3735831 | 9.1.1.37 ↗ | beta barrels › Lipocalins/Streptavidin › Lipocalins › Lipocalins › DUF6314 | 0.51 | 43.0 | 3.68e-01 | 99.2% | 55.0% |
| 3843944 | 243.5.1.7 ↗ | a+b two layers › Cystatin-like › Amine oxidase N-terminal region › Amine oxidase N-terminal region › AKAP28 | 0.51 | 43.0 | 4.29e-01 | 99.2% | 88.0% |
| 3917010 | 243.3.1.20 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › AKAP28 | 0.51 | 43.0 | 4.28e-01 | 100.0% | 88.8% |
D2
high
residues 211-297
Domain cluster:
rep: putative_EGF-like_domain-containing_protein__YP_003987180__Acanthamoeba_polyphaga_mimivirus__212035__D232-303
Pfam (1)
| Accession | Name | Score | E-value | Q cov | HMM cov |
|---|---|---|---|---|---|
| PF28386.1 best | BfoA_C | 43.3 | 6.40e-11 | 93.1% | 60.0% |
D3
high
residues 344-421
D4
medium
residues 425-522